Position in BLLN
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$87,465
+$11,109 QoQ
Shares Held
1,108
+18.8% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BLLN Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026WELLS FARGO & COMPANY/MN holds $2,067,077,099 across 37 Diagnostics & Research names. BLLN ranks #32 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
1,443,512 | $709,529,450 | |
| 2 | DHR |
Danaher Corp /De/
|
2,043,400 | $387,428,638 | |
| 3 | DGX |
Quest Diagnostics Inc
|
1,762,769 | $345,467,465 | |
| 4 | IDXX |
Idexx Laboratories Inc /De
|
208,847 | $117,349,038 | |
| 5 | LH |
Labcorp Holdings Inc.
|
321,411 | $85,755,667 | |
| 6 | NTRA |
Natera, Inc.
|
409,151 | $81,826,106 | |
| 7 | IQV |
Iqvia Holdings Inc.
|
388,264 | $66,214,541 | |
| 8 | WAT |
Waters Corp /De/
|
207,364 | $61,752,996 |
All Filings in BLLN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $87,465 | 1,108 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $76,356 | 933 | Shares | Defined | 2026-02-13 | |
| No filing history on record for this holder in this stock. | ||||||